First-line drugs for hypertension (Q56336831)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29667175 AND SRC:MED&resulttype=core&format=json

23 March 2020

meta-analysis

0 references

title

First-line drugs for hypertension (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29667175 AND SRC:MED&resulttype=core&format=json

23 March 2020

1 reference

James M Wright

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29667175 AND SRC:MED&resulttype=core&format=json

23 March 2020

Vijaya M Musini

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29667175 AND SRC:MED&resulttype=core&format=json

23 March 2020

Rupam Gill

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29667175 AND SRC:MED&resulttype=core&format=json

23 March 2020

publication date

18 April 2018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29667175 AND SRC:MED&resulttype=core&format=json

Cochrane Database of Systematic Reviews

23 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29667175 AND SRC:MED&resulttype=core&format=json

23 March 2020

volume

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29667175 AND SRC:MED&resulttype=core&format=json

23 March 2020

page(s)

CD001841

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29667175 AND SRC:MED&resulttype=core&format=json

Treatment of mild hypertension: results of a ten-year intervention trial

23 March 2020

cites work

1 reference

12 December 2020

Mild hypertension--early drug treatment or follow-up only? The Oslo study

1 reference

12 December 2020

Randomised controlled trial of treatment for mild hypertension: design and pilot trial. Report of Medical Research Council Working Party on Mild to Moderate Hypertension

1 reference

12 December 2020

Antihypertensive therapy in elderly patients. Pilot trial of the European Working Party on High Blood Pressure in the Elderly

1 reference

12 December 2020

Antihypertensive therapy in patients above age 60. Third interim report of the European Working Party on High blood pressure in Elderly (EWPHE)

1 reference

12 December 2020

Evaluation of drug treatment in mild hypertension: VA-NHLBI feasibility trial. Plan and preliminary results of a two-year feasibility trial for a multicenter intervention study to evaluate the benefits versus the disadvantages of treating mild hyper

1 reference

12 December 2020

Antihypertensive Therapy in Patients above Age 60 Years (Fourth Interim Report of the European Working Party on High Blood Pressure in Elderly: EWPHE)

1 reference

12 December 2020

Initial results of the Australian Therapeutic Trial in mild hypertension: Report by the Management Committee

1 reference

12 December 2020

Treatment of mild hypertension. Preliminary results of a two-year feasibility trial

1 reference

12 December 2020

Serum triglycerides and serum uric acid in untreated and thiazide-treated patients with mild hypertension

1 reference

12 December 2020

Medical Research Council's Treatment Trial for mild hypertension: an interim report

1 reference

12 December 2020

A meta-analysis of outcome trials in elderly hypertensives

1 reference

12 December 2020

Some lessons from systolic hypertension in the elderly program (SHEP)

1 reference

12 December 2020

Syst-Eur—A Multicenter Trial on the Treatment of Isolated Systolic Hypertension in the Elderly

1 reference

12 December 2020

Medical Research Council trial of treatment of hypertension in older adults: principal results. MRC Working Party

1 reference

12 December 2020

SYST-EUR: a multicenter trial of treatment of systolic hypertension in aged subjects. An initial report

1 reference

12 December 2020

Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension)

1 reference

12 December 2020

The Effect of Antihypertensive Treatment on Electrocardiogram Voltages in the EWPHE Trial

1 reference

12 December 2020

Treatment of isolated systolic hypertension in the elderly

1 reference

12 December 2020

Prevalence of postural hypotension at baseline in the Systolic Hypertension in the Elderly Program (SHEP) cohort

1 reference

12 December 2020

Syst-Eur. A multicentre trial on the treatment of isolated systolic hypertension in the elderly: Objectives, protocol, and organization

1 reference

12 December 2020

UK Prospective Diabetes Study (UKPDS). VIII. Study design, progress and performance

1 reference

12 December 2020

Systolic Hypertension in the Elderly Program (SHEP). Part 8: Electrocardiographic characteristics

1 reference

12 December 2020

Left ventricular hypertrophy in elderly hypertensive patients: A report from the European Working Party on High Blood Pressure in the Elderly Trial

1 reference

12 December 2020

Risks and benefits in the trial of the European Working Party on High Blood Pressure in the Elderly

1 reference

12 December 2020

Long-term mortality after 5-year multifactorial primary prevention of cardiovascular diseases in middle-aged men.

1 reference

12 December 2020

Blood pressure, stroke, and coronary heart disease

1 reference

12 December 2020

Systolic Hypertension in the Elderly Program (SHEP). Part 7: Baseline laboratory characteristics

1 reference

12 December 2020

Systolic Hypertension of the Elderly Program (SHEP). Part 9: Behavioral characteristics

1 reference

12 December 2020

Systolic Hypertension of the Elderly Program (SHEP). Part 10: Analysis

1 reference

12 December 2020

Systolic Hypertension in the Elderly Program (SHEP). Part 1: Rationale and design

1 reference

12 December 2020

Systolic Hypertension in the Elderly Program (SHEP). Part 3: Sociodemographic characteristics

1 reference

12 December 2020

Systolic Hypertension in the Elderly Program (SHEP). Part 4: Baseline medical history findings

1 reference

12 December 2020

Systolic Hypertension in the Elderly Program (SHEP). Part 6: Baseline physical examination findings.

1 reference

12 December 2020

The European Working Party on High Blood Pressure in the Elderly

1 reference

12 December 2020

1 reference

12 December 2020

Body mass index and prognosis in elderly hypertensive patients: a report from the European Working Party on High Blood Pressure in the Elderly

1 reference

12 December 2020

Adverse treatment effects in the trial of the European Working Party on High Blood Pressure in the Elderly

1 reference

12 December 2020

Renal function in the elderly: results from the European Working Party on High Blood Pressure in the Elderly trial

1 reference

12 December 2020

The determinants and prognostic significance of serum uric acid in elderly patients of the European Working Party on High Blood Pressure in the Elderly trial.

1 reference

12 December 2020

Mortality and treated blood pressure in patients of the European Working Party on High Blood Pressure in the Elderly

1 reference

12 December 2020

Serum cholesterol levels and survival in elderly hypertensive patients: analysis of data from the European Working Party on High Blood Pressure in the Elderly

1 reference

12 December 2020

Further learnings from the European Working Party on High Blood Pressure in the Elderly (EWPHE) study: focus on systolic hypertension

1 reference

12 December 2020

Metoprolol versus thiazide diuretics in hypertension. Morbidity results from the MAPHY Study

1 reference

12 December 2020

Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group

1 reference

12 December 2020

Cardiovascular morbidity and mortality in mild hypertension: the Australian Trial

1 reference

12 December 2020

Relation between mortality and treated blood pressure in elderly patients with hypertension: report of the European Working Party on High Blood Pressure in the Elderly

1 reference

12 December 2020

The Systolic Hypertension in the Elderly Program (SHEP): an intervention trial on isolated systolic hypertension. SHEP Cooperative Research Group

1 reference

12 December 2020

Influence of hypotensive drug treatment in elderly hypertensives: study terminating events in the trial of the European Working Party on High Blood Pressure in the Elderly

1 reference

12 December 2020

Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial

1 reference

12 December 2020

MRC trial of treatment of mild hypertension: principal results. Medical Research Council Working Party

1 reference

12 December 2020

Cardiovascular risk and risk factors in a randomized trial of treatment based on the beta-blocker oxprenolol: the International Prospective Primary Prevention Study in Hypertension (IPPPSH). The IPPPSH Collaborative Group

1 reference

12 December 2020

Coronary heart disease and treatment of hypertension. Some Oslo Study data

1 reference

12 December 2020

Oslo Hypertension Study

1 reference

12 December 2020

Efficacy of antihypertensive drug treatment according to age, sex, blood pressure, and previous cardiovascular disease in patients over the age of 60

1 reference

12 December 2020

Course of blood pressure in mild hypertensives after withdrawal of long term antihypertensive treatment. Medical Research Council Working Party on Mild Hypertension

1 reference

12 December 2020

Beta-blockers versus diuretics in hypertensive men: main results from the HAPPHY trial

1 reference

12 December 2020

Coronary heart disease in the Medical Research Council trial of treatment of mild hypertension. Medical Research Council Working Party on Mild Hypertension

1 reference

12 December 2020

Rationale and design of a randomized clinical trial on prevention of stroke in isolated systolic hypertension. The Systolic Hypertension in the Elderly Program (SHEP) Cooperative Research Group

1 reference

12 December 2020

Morbidity and mortality in the Systolic Hypertension in the Elderly Program (SHEP) pilot study

1 reference

12 December 2020

Isolated systolic hypertension: data from the European Working Party on High Blood Pressure in the Elderly

1 reference

12 December 2020

Randomised trial of treatment of hypertension in elderly patients in primary care

1 reference

12 December 2020

Stroke and coronary heart disease in mild hypertension: risk factors and the value of treatment. Medical Research Council Working Party

1 reference

12 December 2020

Relation of life events to blood pressure control in the SHEP pilot trial

1 reference

12 December 2020

Systolic Hypertension in the Elderly Program, Pilot Study (SHEP-PS): morbidity and mortality experience.

1 reference

12 December 2020

Comparison of the antihypertensive efficacy and adverse reactions to two doses of bendrofluazide and hydrochlorothiazide and the effect of potassium supplementation on the hypotensive action of bendrofluazide: substudies of the Medical Research Coun

1 reference

12 December 2020

Oslo study: treatment of mild hypertension. A five-year controlled drug study

1 reference

12 December 2020

The Australian Therapeutic Trial in Mild Hypertension

1 reference

12 December 2020

Results of MRC (UK) trial of drug therapy for mild hypertension

1 reference

12 December 2020

Primary prevention with metoprolol in patients with hypertension. Mortality results from the MAPHY study

1 reference

12 December 2020

The systolic hypertension in the elderly pilot program: methodological issues

1 reference

12 December 2020

Correlates of blood pressure change in middle-aged male mild hypertensives: results from the untreated control group in the Oslo hypertension trial. The Oslo Study

1 reference

12 December 2020

Influence of antihypertensive drug treatment on morbidity and mortality in patients over the age of 60 years. European Working Party on High blood pressure in the Elderly (EWPHE) results: sub-group analysis on entry stratification

1 reference

12 December 2020

Systolic hypertension in the elderly program (SHEP). The first three months

1 reference

12 December 2020

Glucose intolerance during diuretic therapy in elderly hypertensive patients. A second report from the European Working Party on high blood pressure in the elderly (EWPHE)

1 reference

12 December 2020

Compliance to treatment for hypertension in elderly patients: the SHEP pilot study. Systolic Hypertension in the Elderly Program

1 reference

12 December 2020

Recruitment of elderly volunteers for a multicenter clinical trial: the SHEP pilot study

1 reference

12 December 2020

The need to treat mild hypertension. Misinterpretation of results from the Australian trial.

1 reference

12 December 2020

An international trial of antihypertensive therapy in elderly patients. Objectives, protocol and organization. European Working Party on High Blood Pressure in the Elderly (EWPHE)

1 reference

12 December 2020

Systolic Hypertension in the Elderly Program (SHEP): antihypertensive efficacy of chlorthalidone

1 reference

12 December 2020

Hypotensive therapy in stroke survivors

1 reference

12 December 2020

Control of moderately raised blood pressure. Report of a co-operative randomized controlled trial

1 reference

12 December 2020

European working party on high blood pressure in elderly (EWPHE): organization of a double-blind multicentre trial on antihypertensive therapy in elderly patients

1 reference

12 December 2020

Effect of antihypertensive treatment on stroke recurrence. Hypertension-Stroke Cooperative Study Group

1 reference

12 December 2020

Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 115 through 129 mm Hg

1 reference

12 December 2020

Effects of treatment on morbidity in hypertension. II. Results in patients with diastolic blood pressure averaging 90 through 114 mm Hg

1 reference

12 December 2020

Effects of treatment in hypertension. Results of a controlled study

1 reference

12 December 2020

The Australian therapeutic trial in mild hypertension. Report by the Management Committee

1 reference

12 December 2020

Australian therapeutic trial in mild hypertension

1 reference

12 December 2020

beta-blockers or diuretics in hypertension? A six year follow-up of blood pressure and metabolic side effects

1 reference

12 December 2020

Adverse reactions to bendrofluazide and propranolol for the treatment of mild hypertension. Report of Medical Research Council Working Party on Mild to Moderate Hypertension

1 reference

12 December 2020

Untreated mild hypertension. A report by the Management Committee of the Australian Therapeutic Trial in Mild Hypertension

1 reference

12 December 2020

Australian Therapeutic Trial in Mild Hypertension

1 reference

12 December 2020

Antihypertensive therapy in elderly patients. Ninth interim report. The European Working Party on High Blood Pressure in the Elderly (EWPHE)

1 reference

12 December 2020

The Australian therapeutic trial in mild hypertension

1 reference

12 December 2020

Blood lipids and antihypertensive drugs. The Oslo study

1 reference

12 December 2020

The Oslo study: CHD risk factors, socioeconomic influences, and intervention

1 reference

12 December 2020

Serum glucose levels during long-term observation of treated and untreated men with mild hypertension. The Oslo study

1 reference

12 December 2020

Effect of stepped care treatment on the incidence of myocardial infarction and angina pectoris. 5-Year findings of the hypertension detection and follow-up program

1 reference

12 December 2020

Comparison of propranolol and hydrochlorothiazide for the initial treatment of hypertension. II. Results of long-term therapy. Veterans Administration Cooperative Study Group on Antihypertensive Agents

1 reference

12 December 2020

Blood pressure reduction in elderly: a randomised controlled trial of methyldopa

1 reference

12 December 2020

Treatment of mild hypertension: a five year controlled drug trial. The Oslo study

1 reference

12 December 2020

Prospective study on the treatment of mild hypertension in the aged

1 reference

12 December 2020

Treatment of mild hypertension in the elderly. A study initiated and administered by the National Heart Foundation of Australia

1 reference

12 December 2020

Coronary risk factors and their possible causal role in the development of coronary heart disease: the Oslo study

1 reference

12 December 2020

Failure of therapy to improve prognosis in elderly males with hypertension

1 reference

12 December 2020

Correlates of ventricular ectopic activity in isolated systolic hypertension. SHEP Cooperative Research Group

1 reference

12 December 2020

The effect of chlorthalidone on ventricular ectopic activity in patients with isolated systolic hypertension. The SHEP Study Group

1 reference

12 December 2020

Does antihypertensive treatment of the elderly prevent cardiovascular events or prolong life? A meta-analysis of hypertension treatment trials

1 reference

12 December 2020

A 12-month comparison of ACE inhibitor and CA antagonist therapy in mild to moderate essential hypertension--The GLANT Study. Study Group on Long-term Antihypertensive Therapy

1 reference

12 December 2020

Drug treatment of hypertension in the elderly: a meta-analysis

1 reference

12 December 2020

Treatment of elderly hypertensives in Japan: National Intervention Cooperative Study in Elderly Hypertensives. The National Intervention Cooperative Study Group

1 reference

12 December 2020

The Hypertension in the Very Elderly Trial (HYVET). Rationale, methodology and comparison with previous trials

1 reference

12 December 2020

Effect of two different therapeutic approaches on total and cardiovascular mortality in a Cardiovascular Study in the Elderly (CASTEL).

1 reference

12 December 2020

Age, race, and gender variation in the utilization of coronary artery bypass surgery and angioplasty in SHEP. SHEP Cooperative Research Group. Systolic Hypertension in the Elderly Program

1 reference

12 December 2020

The Hypertension in the Very Elderly Trial (HYVET)

1 reference

12 December 2020

Hypertension in the elderly. Implications and generalizability of randomized trials

1 reference

12 December 2020

STOP-Hypertension 2: a prospective intervention trial of "newer" versus "older" treatment alternatives in old patients with hypertension. Swedish Trial in Old Patients with Hypertension

1 reference

12 December 2020

Statistical considerations in monitoring the Systolic Hypertension in the Elderly Program (SHEP).

1 reference

12 December 2020

[Systolic hypertension in the elderly: Chinese trial (Syst-China)--second interim report]

1 reference

12 December 2020

The Effects of Blood Pressure Reduction in Older Patients: An Overview of Five Randomized Controlled Trials in Elderly Hypertensives

1 reference

12 December 2020

Treatment of Mild Hypertension Study. Final results. Treatment of Mild Hypertension Study Research Group

1 reference

12 December 2020

Nitrendipine in older patients with isolated systolic hypertension: second progress report on the SYST-EUR trial

1 reference

12 December 2020

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group

1 reference

12 December 2020

Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.

1 reference

12 December 2020

Trial of secondary prevention with atenolol after transient ischemic attack or nondisabling ischemic stroke. The Dutch TIA Trial Study Group

1 reference

12 December 2020

SYST-EUR multicentre trial on the treatment of isolated systolic hypertension in the elderly: first interim report.

1 reference

12 December 2020

The Hypertension Optimal Treatment (HOT) Study: 12-month data on blood pressure and tolerability. With special reference to age and gender

1 reference

12 December 2020

Post-stroke antihypertensive treatment study. A preliminary result

1 reference

12 December 2020

Long-term safety and efficacy of moexipril alone and in combination with hydrochlorothiazide in elderly patients with hypertension.

1 reference

12 December 2020

Change in depression as a precursor of cardiovascular events. SHEP Cooperative Research Group (Systoloc Hypertension in the elderly).

1 reference

12 December 2020

The HOPE (Heart Outcomes Prevention Evaluation) Study: the design of a large, simple randomized trial of an angiotensin-converting enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular events. The HOPE study investigat

1 reference

12 December 2020

New meta-analysis of treatment trials of hypertension: improving the estimate of therapeutic benefit.

1 reference

12 December 2020

Rationale and design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). ALLHAT Research Group

1 reference

12 December 2020

Final outcome results of the Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS). A randomized controlled trial

1 reference

12 December 2020

Evaluating the benefits of an antihypertensive agent using trials based on event and organ damage: the Systolic Hypertension in the Elderly Long-term Lacidipine (SHELL) trial and the European Lacidipine Study on Atherosclerosis (ELSA).

1 reference

12 December 2020

INSIGHT: international nifedipine GITS study intervention as a goal in hypertension treatment

1 reference

12 December 2020

Shanghai trial of nifedipine in the elderly (STONE)

1 reference

12 December 2020

Serum lipids and incidence of coronary heart disease. Findings from the Systolic Hypertension in the Elderly Program (SHEP).

1 reference

12 December 2020

Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group

1 reference

12 December 2020

Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis

1 reference

12 December 2020

Blinded subjective rankings as a method of assessing treatment effect: a large sample example from the Systolic Hypertension in the Elderly Program (SHEP).

1 reference

12 December 2020

Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia)

1 reference

12 December 2020

Prevention of heart failure by antihypertensive drug treatment in older persons with isolated systolic hypertension. SHEP Cooperative Research Group

1 reference

12 December 2020

Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators

1 reference

12 December 2020

Clinical results of the Verapamil in Hypertension and Atherosclerosis Study

1 reference

12 December 2020

Mortality over Four Years in SHEP Participants with a Low Ankle‐Arm Index

1 reference

12 December 2020

Influence of long-term, low-dose, diuretic-based, antihypertensive therapy on glucose, lipid, uric acid, and potassium levels in older men and women with isolated systolic hypertension: The Systolic Hypertension in the Elderly Program. SHEP Cooperat

1 reference

12 December 2020

Subgroup and per-protocol analysis of the randomized European Trial on Isolated Systolic Hypertension in the Elderly

1 reference

12 December 2020

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

1 reference

12 December 2020

Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. UK Prospective Diabetes Study Group

1 reference

12 December 2020

Systematic review of antihypertensive therapies: does the evidence assist in choosing a first-line drug?

1 reference

12 December 2020

Antihypertensive drugs in very old people: a subgroup meta-analysis of randomised controlled trials. INDANA Group

1 reference

12 December 2020

Orthostatic fall in blood pressure in the very elderly hypertensive: results from the hypertension in the very elderly trial (HYVET) - pilot

1 reference

12 December 2020

Efficacy of treating hypertension in women

1 reference

12 December 2020

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

1 reference

12 December 2020

Relation of low body mass to death and stroke in the systolic hypertension in the elderly program. The SHEP Cooperative Research Group

1 reference

12 December 2020

Benefit of antihypertensive treatment in the diabetic patients enrolled in the Systolic Hypertension in Europe (Syst-Eur) trial

1 reference

12 December 2020

Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group

1 reference

12 December 2020

Pharmacotherapy for hypertension in the elderly.

1 reference

12 December 2020

Effect of treating isolated systolic hypertension on the risk of developing various types and subtypes of stroke: the Systolic Hypertension in the Elderly Program (SHEP)

1 reference

12 December 2020

Effects of antihypertensive treatment on endpoints in the diabetic patients randomized in the Systolic Hypertension in Europe (Syst-Eur) trial.

1 reference

12 December 2020

Randomized, placebo-controlled trial of the angiotensin-converting enzyme inhibitor, ramipril, in patients with coronary or other occlusive arterial disease

1 reference

12 December 2020

Serum uric acid, diuretic treatment and risk of cardiovascular events in the Systolic Hypertension in the Elderly Program (SHEP)

1 reference

12 December 2020

Randomised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study

1 reference

12 December 2020

Long-term effects of cholesterol lowering and angiotensin-converting enzyme inhibition on coronary atherosclerosis: The Simvastatin/Enalapril Coronary Atherosclerosis Trial (SCAT).

1 reference

12 December 2020

Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration

1 reference

12 December 2020

Treatment of arterial hypertension with diuretics, beta- and calcium channel blockers in old patients

1 reference

12 December 2020

The QUinapril Ischemic Event Trial (QUIET): evaluation of chronic ACE inhibitor therapy in patients with ischemic heart disease and preserved left ventricular function

1 reference

12 December 2020

Isolated Systolic Hypertension, Morbidity, and Mortality: The SHEP Experience

1 reference

12 December 2020

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

1 reference

12 December 2020

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

1 reference

12 December 2020

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

1 reference

12 December 2020

Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack

1 reference

12 December 2020

Cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial of patients with type 2 diabetes and overt nephropathy

1 reference

12 December 2020

The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial

1 reference

12 December 2020

Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis

1 reference

12 December 2020

Long term effects of nisoldipine on the progression of coronary atherosclerosis and the occurrence of clinical events: the NICOLE study

1 reference

12 December 2020

Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study).

1 reference

12 December 2020

Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials

1 reference

12 December 2020

Results of the pilot study for the Hypertension in the Very Elderly Trial

1 reference

12 December 2020

Effects of low-dose angiotensin II receptor blocker candesartan on cardiovascular events in patients with coronary artery disease

1 reference

12 December 2020

Effects of low dose ramipril on cardiovascular and renal outcomes in patients with type 2 diabetes and raised excretion of urinary albumin: randomised, double blind, placebo controlled trial (the DIABHYCAR study).

1 reference

12 December 2020

A systematic review and meta-analysis of the efficacy and safety of a fixed, low-dose perindopril-indapamide combination as first-line treatment of hypertension

1 reference

12 December 2020

Preventing microalbuminuria in type 2 diabetes

1 reference

12 December 2020

Angiotensin-converting-enzyme inhibition in stable coronary artery disease

1 reference

12 December 2020

Thiazide-like diuretics attenuate agonist-induced vasoconstriction by calcium desensitization linked to Rho kinase

1 reference

12 December 2020

How do thiazide and thiazide-like diuretics lower blood pressure?

1 reference

12 December 2020

Effects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus: results of prospectively designed overviews of randomized trials

1 reference

12 December 2020

Apparent effect on blood pressure is only partly responsible for the risk reduction due to antihypertensive treatments

1 reference

12 December 2020

Effect of ramipril on the incidence of diabetes

1 reference

12 December 2020

Predictors of antihypertensive drug responses: initial data from a placebo-controlled, randomized, cross-over study with four antihypertensive drugs (The GENRES Study).

1 reference

12 December 2020

Comparison of valsartan/hydrochlorothiazide combination therapy at doses up to 320/25 mg versus monotherapy: a double-blind, placebo-controlled study followed by long-term combination therapy in hypertensive adults

1 reference

12 December 2020

Renoprotection of Optimal Antiproteinuric Doses (ROAD) Study: a randomized controlled study of benazepril and losartan in chronic renal insufficiency

1 reference

12 December 2020

The spironolactone, amiloride, losartan, and thiazide (SALT) double-blind crossover trial in patients with low-renin hypertension and elevated aldosterone-renin ratio

1 reference

12 December 2020

Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial

1 reference

12 December 2020

Effects of angiotensin-converting enzyme inhibition in low-risk patients early after coronary artery bypass surgery

1 reference

12 December 2020

Treatment of hypertension in patients 80 years of age or older

1 reference

12 December 2020

Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial

1 reference

12 December 2020

Telmisartan to prevent recurrent stroke and cardiovascular events

1 reference

12 December 2020

Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial

1 reference

12 December 2020

Long-term antihypertensive efficacy and safety of the oral direct renin inhibitor aliskiren: a 12-month randomized, double-blind comparator trial with hydrochlorothiazide

1 reference

12 December 2020

Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies

1 reference

12 December 2020

Pharmacotherapy for hypertension in the elderly

1 reference

12 December 2020

Effect of valsartan on the incidence of diabetes and cardiovascular events

1 reference

12 December 2020

Mechanisms for blood pressure lowering and metabolic effects of thiazide and thiazide-like diuretics

1 reference

12 December 2020

Calcium channel blockers versus other classes of drugs for hypertension

1 reference

12 December 2020

Prevention of hypertension in patients with pre-hypertension: protocol for the PREVER-prevention trial

1 reference

12 December 2020

Olmesartan for the Delay or Prevention of Microalbuminuria in Type 2 Diabetes

1 reference

12 December 2020

Irbesartan in Patients with Atrial Fibrillation

1 reference

12 December 2020

Effects of olmesartan on renal and cardiovascular outcomes in type 2 diabetes with overt nephropathy: a multicentre, randomised, placebo-controlled study.

1 reference

12 December 2020

Pharmacotherapy for mild hypertension

1 reference

12 December 2020

Effects of blood pressure lowering on outcome incidence in hypertension. 1. Overview, meta-analyses, and meta-regression analyses of randomized trials.

1 reference

12 December 2020

Pharmacotherapy for hypertension in older adults: a systematic review

1 reference

12 December 2020

Effects of blood pressure lowering in patients with acute ischemic stroke and carotid artery stenosis

1 reference

12 December 2020

Effects of Blood Pressure Reduction in Mild Hypertension

1 reference

12 December 2020

First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension

1 reference

12 December 2020

Randomized controlled trials of blood pressure lowering in hypertension: a critical reappraisal

1 reference

12 December 2020

Effects of blood pressure-lowering treatment. 6. Prevention of heart failure and new-onset heart failure – meta-analyses of randomized trials

1 reference

12 December 2020

The effect of antihypertensive treatment on the incidence of stroke and cognitive decline in the elderly: a meta-analysis

1 reference

12 December 2020

Antihypertensive pharmacotherapy for prevention of sudden cardiac death in hypertensive individuals

1 reference

12 December 2020

Blood-Pressure Lowering in Intermediate-Risk Persons without Cardiovascular Disease

1 reference

12 December 2020

Association of 3 Different Antihypertensive Medications With Hip and Pelvic Fracture Risk in Older Adults: Secondary Analysis of a Randomized Clinical Trial.

1 reference

12 December 2020

Renin-angiotensin-aldosterone system blockers and cardiovascular outcomes: a meta-analysis of randomized clinical trials

1 reference

12 December 2020

Beta-blockers for hypertension.

1 reference

12 December 2020

Pharmacotherapy for hypertension in adults aged 18 to 59 years.

1 reference

12 December 2020

10.1002/14651858.CD001841.PUB3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29667175 AND SRC:MED&resulttype=core&format=json

23 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29667175 AND SRC:MED&resulttype=core&format=json

23 March 2020

PubMed publication ID

29667175

1 reference